Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment. The company now expects additional inflationary impacts and lower volumes resulting primarily from global supply chain constraints, and a lower-than-expected offset from pricing actions. The company estimates this incremental impact will be approximately $150 million to $175 million to fiscal year 2022 Medical segment profit and approximately $0.40 to $0.45 per share to non-GAAP diluted EPS. Excluding this impact to the Medical segment and non-GAAP diluted EPS, the company's other financial expectations1 for fiscal year 2022 remain unchanged.
https://finance.yahoo.com/news/cardinal-health-provides-medical-segment-115500375.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.